To develop and validate prediction tool for contrast-induced nephropathy (CIN) in patients undergoing contemporary percutaneous coronary intervention (PCI) or coronary angiogram (CAG). A total of 3,469 patients undergoing PCI/CAG between… Click to show full abstract
To develop and validate prediction tool for contrast-induced nephropathy (CIN) in patients undergoing contemporary percutaneous coronary intervention (PCI) or coronary angiogram (CAG). A total of 3,469 patients undergoing PCI/CAG between January 2010 and December 2013 were randomly divided into a
               
Click one of the above tabs to view related content.